| Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients R Cervera, R Serrano, GJ Pons-Estel, L Ceberio-Hualde, Y Shoenfeld, ... Annals of the rheumatic diseases 74 (6), 1011-1018, 2015 | 828 | 2015 |
| Increased microRNA-146a/b, TRAF6 gene and decreased IRAK1 gene expressions in the peripheral mononuclear cells of patients with Sjögren's syndrome E Zilahi, T Tarr, G Papp, Z Griger, S Sipka, M Zeher Immunology letters 141 (2), 165-168, 2012 | 156 | 2012 |
| Similarities and differences between pediatric and adult patients with systemic lupus erythematosus T Tarr, B Dérfalvi, N Győri, A Szántó, Z Siminszky, A Malik, AJ Szabó, ... Lupus 24 (8), 796-803, 2015 | 155 | 2015 |
| Anti‐vitamin D, vitamin D in SLE: preliminary results JF Carvalho, M Blank, E Kiss, T Tarr, H Amital, Y Shoenfeld Annals of the New York Academy of Sciences 1109 (1), 550-557, 2007 | 154 | 2007 |
| A comprehensive investigation on the distribution of circulating follicular T helper cells and B cell subsets in primary Sjögren’s syndrome and systemic lupus erythematosus K Szabó, G Papp, A Szántó, T Tarr, M Zeher Clinical & Experimental Immunology 183 (1), 76-89, 2016 | 150 | 2016 |
| MicroRNA expression profiles identify disease-specific alterations in systemic lupus erythematosus and primary Sjögren's syndrome JQ Chen, G Papp, S Póliska, K Szabó, T Tarr, BL Bálint, P Szodoray, ... PloS one 12 (3), e0174585, 2017 | 115 | 2017 |
| Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients T Tarr, G Lakos, HP Bhattoa, Y Shoenfeld, G Szegedi, E Kiss Lupus 16 (1), 39-45, 2007 | 115 | 2007 |
| Reduced flow-mediated vasodilation as a marker for cardiovascular complications in lupus patients E Kiss, P Soltesz, H Der, Z Kocsis, T Tarr, H Bhattoa, Y Shoenfeld, ... Journal of autoimmunity 27 (4), 211-217, 2006 | 111 | 2006 |
| The immunopathological role of vitamin D in patients with SLE: data from a single centre registry in Hungary P Szodoray, T Tarr, A Bazso, G Poor, G Szegedi, E Kiss Scandinavian journal of rheumatology 40 (2), 122-126, 2011 | 105 | 2011 |
| Measurement of natural (CD4+ CD25high) and inducible (CD4+ IL-10+) regulatory T cells in patients with systemic lupus erythematosus S Barath, M Aleksza, T Tarr, S Sipka, G Szegedi, E Kiss Lupus 16 (7), 489-496, 2007 | 92 | 2007 |
| Reduced paraoxonase1 activity is a risk for atherosclerosis in patients with systemic lupus erythematosus E Kiss, I Seres, T Tarr, Z Kocsis, G Szegedi, G Paragh Annals of the New York Academy of Sciences 1108 (1), 83-91, 2007 | 83 | 2007 |
| Occurrence of malignancies in Hungarian patients with systemic lupus erythematosus: results from a single center T Tarr, B Gyorfy, E Szekanecz, HP Bhattoa, M Zeher, G Szegedi, E Kiss Annals of the New York Academy of Sciences 1108 (1), 76-82, 2007 | 71 | 2007 |
| Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: associations with organ manifestations, immunolaboratory markers and disease activity indices É Szekanecz, G Szűcs, Z Szekanecz, T Tarr, P Antal-Szalmás, S Szamosi, ... Journal of autoimmunity 31 (4), 372-376, 2008 | 69 | 2008 |
| Primary antiphospholipid syndrome as the forerunner of systemic lupus erythematosus T Tarr, G Lakos, HP Bhattoa, G Szegedi, Y Shoenfeld, E Kiss Lupus 16 (5), 324-328, 2007 | 68 | 2007 |
| High-density lipopoprotein antioxidant capacity, subpopulation distribution and paraoxonase-1 activity in patients with systemic lupus erythematosus K Gaál, T Tarr, H Lőrincz, V Borbás, I Seres, M Harangi, P Fülöp, ... Lipids in health and disease 15, 1-8, 2016 | 65 | 2016 |
| Clinical thrombotic manifestations in SLE patients with and without antiphospholipid antibodies: a 5-year follow-up T Tarr, G Lakos, HP Bhattoa, P Soltesz, Y Shoenfeld, G Szegedi, E Kiss Clinical reviews in allergy & immunology 32, 131-137, 2007 | 61 | 2007 |
| Decreased apopto-phagocytic gene expression in the macrophages of systemic lupus erythematosus patients G Majai, E Kiss, T Tarr, G Zahuczky, Z Hartman, G Szegedi, L Fésüs Lupus 23 (2), 133-145, 2014 | 59 | 2014 |
| Chronic high-dose glucocorticoid therapy triggers the development of chronic organ damage and worsens disease outcome in systemic lupus erythematosus T Tarr, G Papp, N Nagy, E Cserép, M Zeher Clinical rheumatology 36, 327-333, 2017 | 47 | 2017 |
| Interleukin-23 receptor gene variants in Hungarian systemic lupus erythematosus patients E Safrany, R Hobor, L Jakab, T Tarr, V Csongei, L Jaromi, C Sipeky, ... Inflammation research 59, 159-164, 2010 | 37 | 2010 |
| Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus P Szodoray, T Tarr, J Tumpek, J Kappelmayer, G Lakos, G Poor, ... Autoimmunity 42 (6), 497-506, 2009 | 28 | 2009 |
Zeher MargitDebreceni Egyetem Orvos és Egészségtudományi Centrum Belgyógyászati Intézet Klinikai ImmunológiaVerified email at iiibel.dote.hu
